Cargando…
CAH Newborn Screening in India: Challenges and Opportunities
Congenital adrenal hyperplasia (CAH) is a common treatable disorder which is associated with life-threatening adrenal crisis, sexual ambiguity, and/or abnormal growth if undiagnosed. Newborn screening is a cost-effective tool to detect affected babies early after birth to optimize their treatment an...
Autores principales: | Dabas, Aashima, Bothra, Meenakshi, Kapoor, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570061/ https://www.ncbi.nlm.nih.gov/pubmed/33239596 http://dx.doi.org/10.3390/ijns6030070 |
Ejemplares similares
-
Newborn Screening for CAH—Challenges and Opportunities
por: Heather, Natasha L., et al.
Publicado: (2021) -
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021) -
Newborn screening- the roadmap for India
por: Kapoor, Seema
Publicado: (2014) -
Diagnosis and prevalence of Congenital Adrenal Hyperplasia (CAH) in Austrian children screened or not screened for CAH
por: Luxenberger, Katharina, et al.
Publicado: (2013) -
Comprehensive and Cost-Effective Strategy for Genetic Screening of Congenital Adrenal Hyperplasia (CAH) in India
por: Ravichandran, Lavanya, et al.
Publicado: (2021)